Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Aptose Bioscns (APTO)

1.49 +0.04 (+2.76%)

8/17/2017  4:00pm

Open:

1.45

Pre. Close:

1.45

High:

1.50

Low:

1.45

Volume:

223,767

Market Cap:

35.80M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.52 - 1.53

1.53 - 1.54

Low:

1.39 - 1.4

1.4 - 1.42

Close:

1.46 - 1.48

1.48 - 1.51

Technical analysis  (as of: 2017-08-17 4:33:58 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 1.84     One year: 2.04

Support:

Support1: 1.30    Support2: 1.08

Resistance:

Resistance1: 1.58    Resistance2: 1.75

Pivot:

1.52

Moving Averages:

MA(5): 1.47     MA(20): 1.51

MA(100): 1.21     MA(250): 1.35

MACD:

MACD(12,26): 0.03     Signal(12,26,9): 0.05

%K %D:

%K(14,3): 37.12     %D(3): 35.61

RSI:

RSI(14): 51.35

52-Week:

High: 3.20  Low: 0.78  Change(%): -32.9

Average Vol(K):

3-Month: 37278  10-Days 17624

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
APTO has closed above bottom band by 40.2%. Bollinger Bands are 11.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 04 Nov 2016 14:58:05 GMT
Aptose Remains In Limbo

Fri, 04 Aug 2017 11:03:45 GMT
How These Biotech Stocks are Performing? -- Agenus, Aptose Biosciences, RXi ...

Wed, 16 Nov 2016 03:44:26 GMT
Aptose Biosciences' (APTO) CEO William Rice on Q3 2016 Results - Earnings Call ...

Tue, 06 Jun 2017 20:03:45 GMT
Aptose Biosciences Announces Results of Annual Meeting of Shareholders

Thu, 29 Dec 2016 12:56:15 GMT
Aptose Biosciences Provides Update on APTO-253 Development

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

18.94

Shares Float (M)

19.68

% Held by Insiders

10.10

% Held by Institutions

26.60

Shares Short (K)

1140

Shares Short Prior Month (K)

1020

Stock Financials

EPS

-0.980

EPS Est. Current Year

-1.170

EPS Est. Next Year

-0.680

EPS Est. Next Quarter

-0.220

Forward EPS

-0.691

Book Value (p.s.)

0.420

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-78.5

Return on Equity (ttm)

-145.1

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.757

Qtrly Earnings Growth

Operating Cash Flow (M)

-12.29

Levered Free Cash Flow (M)

-7.03

FoxReading.com

Valuation

P/E

-1.52

P/E Growth Ratio

0.03

P/BV

3.55

P/S

P/CF

-2.30

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.